These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 5065530)

  • 1. Morphine catalepsy in the rat: relation to striatal dopamine metabolism.
    Kuschinsky K; Hornykiewicz O
    Eur J Pharmacol; 1972 Jul; 19(1):119-22. PubMed ID: 5065530
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessing NH300094, a novel dopamine and serotonin receptor modulator with cognitive enhancement property for treating schizophrenia.
    Feng Z; Hu Z; Li L; Yu M; Zhang Y; Jing P; Xu X; Wu J; Hu Y; Xu X
    Front Pharmacol; 2024; 15():1298061. PubMed ID: 38327987
    [No Abstract]   [Full Text] [Related]  

  • 3. Taurine and coenzyme Q10 synergistically prevent and reverse chlorpromazine-induced psycho-neuroendocrine changes and cataleptic behavior in rats.
    Oyovwi MO; Nwangwa EK; Ben-Azu B; Edesiri TP; Emojevwe V; Igweh JC
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Apr; 394(4):717-734. PubMed ID: 33146779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditioned increase of locomotor activity induced by haloperidol.
    De la Casa LG; Cárcel L; Ruiz-Salas JC; Vicente L; Mena A
    PLoS One; 2018; 13(10):e0200178. PubMed ID: 30281607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microglia ablation alleviates myelin-associated catatonic signs in mice.
    Janova H; Arinrad S; Balmuth E; Mitjans M; Hertel J; Habes M; Bittner RA; Pan H; Goebbels S; Begemann M; Gerwig UC; Langner S; Werner HB; Kittel-Schneider S; Homuth G; Davatzikos C; Völzke H; West BL; Reif A; Grabe HJ; Boretius S; Ehrenreich H; Nave KA
    J Clin Invest; 2018 Feb; 128(2):734-745. PubMed ID: 29252214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical network dysfunction caused by a subtle defect of myelination.
    Poggi G; Boretius S; Möbius W; Moschny N; Baudewig J; Ruhwedel T; Hassouna I; Wieser GL; Werner HB; Goebbels S; Nave KA; Ehrenreich H
    Glia; 2016 Nov; 64(11):2025-40. PubMed ID: 27470661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimulation of δ opioid receptor and blockade of nociceptin/orphanin FQ receptor synergistically attenuate parkinsonism.
    Mabrouk OS; Viaro R; Volta M; Ledonne A; Mercuri N; Morari M
    J Neurosci; 2014 Sep; 34(39):12953-62. PubMed ID: 25253844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging.
    Longo F; Russo I; Shimshek DR; Greggio E; Morari M
    Neurobiol Dis; 2014 Nov; 71():62-73. PubMed ID: 25107341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic antiparkinsonian effects of the novel nociceptin/orphanin FQ receptor antagonist NiK-21273 in comparison with SB-612111.
    Marti M; Mela F; Budri M; Volta M; Malfacini D; Molinari S; Zaveri NT; Ronzoni S; Petrillo P; Calò G; Morari M
    Br J Pharmacol; 2013 Feb; 168(4):863-79. PubMed ID: 22994368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A myelin gene causative of a catatonia-depression syndrome upon aging.
    Hagemeyer N; Goebbels S; Papiol S; Kästner A; Hofer S; Begemann M; Gerwig UC; Boretius S; Wieser GL; Ronnenberg A; Gurvich A; Heckers SH; Frahm J; Nave KA; Ehrenreich H
    EMBO Mol Med; 2012 Jun; 4(6):528-39. PubMed ID: 22473874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine reduces antipsychotic-induced orofacial dyskinesia in rats.
    Bordia T; McIntosh JM; Quik M
    J Pharmacol Exp Ther; 2012 Mar; 340(3):612-9. PubMed ID: 22144565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cannabinoid receptor agonist, WIN 55, 212-2, attenuates tumor-evoked hyperalgesia through peripheral mechanisms.
    Potenzieri C; Harding-Rose C; Simone DA
    Brain Res; 2008 Jun; 1215():69-75. PubMed ID: 18486111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and chronic administration of the cannabinoid receptor agonist CP 55,940 attenuates tumor-evoked hyperalgesia.
    Hamamoto DT; Giridharagopalan S; Simone DA
    Eur J Pharmacol; 2007 Mar; 558(1-3):73-87. PubMed ID: 17250825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAUC 213, a highly selective dopamine D4 receptor full antagonist, exhibits atypical antipsychotic properties in behavioural and neurochemical models of schizophrenia.
    Boeckler F; Russig H; Zhang W; Löber S; Schetz J; Hübner H; Ferger B; Gmeiner P; Feldon J
    Psychopharmacology (Berl); 2004 Aug; 175(1):7-17. PubMed ID: 15007532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic-like effects of gamma-hydroxybutyrate: interactions with haloperidol and dizocilpine.
    Sevak RJ; France CP; Koek W
    Eur J Pharmacol; 2004 Jan; 483(2-3):289-93. PubMed ID: 14729119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine-induced hyperactivity in rats--a rebound effect?
    Magnus-Ellenbroek B; Havemann-Reinecke U
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):635-42. PubMed ID: 8361550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in morphine reinforcement property in two inbred rat strains: associations with cortical receptors, behavioral activity, analgesia and the cataleptic effects of morphine.
    Sudakov SK; Goldberg SR; Borisova EV; Surkova LA; Turina IV; Rusakov DJu ; Elmer GI
    Psychopharmacology (Berl); 1993; 112(2-3):183-8. PubMed ID: 7871017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of intraventricular 6-hydroxydopamine and 5,6-dihydroxytryptamine on morphine induced locomotor stimulation.
    Slater P; Blundell C
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jul; 312(3):219-24. PubMed ID: 7402365
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of morphine and methionine-enkephalin on the release of purines from cerebral cortex slices of rats and mice.
    Stone TW
    Br J Pharmacol; 1981 Sep; 74(1):171-6. PubMed ID: 7272599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cataleptogenic doses of morphine suppress 3H-spiroperidol binding to striatal membranes.
    Golembiowska-Nikitin K; Pilc A; Vetulani J
    Naunyn Schmiedebergs Arch Pharmacol; 1982 May; 319(2):140-1. PubMed ID: 7202125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.